Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ.

MLA

Ferri, Lorenzo, et al. “Functional and Pharmacological Evaluation of Novel GLA Variants in Fabry Disease Identifies Six (Two de Novo) Causative Mutations and Two Amenable Variants to the Chaperone DGJ.” Clinica Chimica Acta, vol. 481, June 2018, pp. 25–33. EBSCOhost, https://doi.org/10.1016/j.cca.2018.02.021.

APA

Ferri, L., Malesci, D., Fioravanti, A., Bagordo, G., Filippini, A., Ficcadenti, A., Manna, R., Antuzzi, D., Verrecchia, E., Donati, I., Mignani, R., Cavicchi, C., Guerrini, R., & Morrone, A. (2018). Functional and pharmacological evaluation of novel GLA variants in Fabry disease identifies six (two de novo) causative mutations and two amenable variants to the chaperone DGJ. Clinica Chimica Acta, 481, 25–33. https://doi.org/10.1016/j.cca.2018.02.021

Chicago

Ferri, Lorenzo, Duccio Malesci, Antonella Fioravanti, Gaia Bagordo, Armando Filippini, Anna Ficcadenti, Raffaele Manna, et al. 2018. “Functional and Pharmacological Evaluation of Novel GLA Variants in Fabry Disease Identifies Six (Two de Novo) Causative Mutations and Two Amenable Variants to the Chaperone DGJ.” Clinica Chimica Acta 481 (June): 25–33. doi:10.1016/j.cca.2018.02.021.